Hancock Jaffe Laboratories 

$10.24
7
-$0.14-1.35% Friday 20:00

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
87.18M
P/E Ratio
0
Dividend Yield
-
Dividend
-

Upcoming

Earnings

4MayExpected
Q2 2024
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Next
-10.5
-7.07
-3.65
-0.22
Expected EPS
-8.4
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2017
2018
2019
2020
2021
2022
0Revenue
-60.88MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow HJLI. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Medtronic
MDT
Mkt Cap111.22B
Medtronic is a major player in the medical devices sector, offering products that can compete directly with enVVeno Medical's neurovascular and cardiovascular solutions.
Boston Scientific
BSX
Mkt Cap93.36B
Boston Scientific competes in the medical devices market, particularly in areas overlapping with enVVeno Medical's focus on neurovascular treatments.
Abbott Laboratories
ABT
Mkt Cap178.76B
Abbott Laboratories offers a wide range of medical devices, including those for cardiovascular and neuromodulation, making it a direct competitor.
Smith & Nephew
SNN
Mkt Cap13.72B
Smith & Nephew operates in the medical technology field, with products that could compete in the surgical sectors where enVVeno Medical may be involved.
Stryker
SYK
Mkt Cap126.97B
Stryker is known for its medical devices and equipment, competing in the neurotechnology and spine sector, which may overlap with enVVeno Medical's offerings.
Johnson & Johnson
JNJ
Mkt Cap585.7B
Johnson & Johnson, through its medical devices segment, competes across a broad range of healthcare products, including those that could be in direct competition with enVVeno Medical.
Zimmer Biomet
ZBH
Mkt Cap18.01B
Zimmer Biomet Holdings, Inc. competes in the musculoskeletal healthcare sector, which could include products and technologies competitive with enVVeno Medical's.
Edwards Lifesciences
EW
Mkt Cap47.07B
Edwards Lifesciences specializes in heart valves and hemodynamic monitoring, areas that could see overlap with enVVeno Medical's cardiovascular solutions.
Intuitive Surgical
ISRG
Mkt Cap160.56B
Intuitive Surgical, known for its da Vinci surgical systems, competes in the innovative surgical solutions space, potentially overlapping with enVVeno Medical's market.
Integra Lifesciences
IART
Mkt Cap935.48M
Integra LifeSciences, a provider of regenerative technologies, neurosurgical, and extremity orthopedic solutions, competes in areas that may overlap with enVVeno Medical's focus.

About

Health Technology
Medical Specialties
Manufacturing
Surgical and Medical Instrument Manufacturing
Hancock Jaffe Laboratories, Inc. is a development stage medical device company, which develops tissue based solutions that are designed to be life sustaining or life enhancing for patients with cardiovascular disease, and peripheral arterial and venous disease. The company is headquartered in Irvine, California and currently employs 9 full-time employees. The firm is developing biologic-based solutions that are designed to be life enhancing for patients with cardiovascular disease, peripheral arterial and venous disease, and end stage renal disease (ESRD). The firm is in the process of developing bioprosthetic implantable devices for cardiovascular disease. The Company’s Bioprosthetic Heart Valve (BHV), is a bioprosthetic, pig heart valve designed to function like a native heart valve, and designed to provide a patient greater functional performance than available devices. The Company’s product Venous Valve is a bioprosthetic, pig venous valve for patients with lower limb chronic venous insufficiency (CVI), which occurs because of damage to the valves of the veins in the legs after patients develop blood clots in the deep venous system.
Show more...
CEO
Employees
19
Country
US
ISIN
US41015N1063

Listings

0 Comments

Share your thoughts

FAQ

What is Hancock Jaffe Laboratories stock price today?
The current price of HJLI is $10.24 USD — it has decreased by -1.35% in the past 24 hours. Watch Hancock Jaffe Laboratories stock price performance more closely on the chart.
What is Hancock Jaffe Laboratories stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Hancock Jaffe Laboratories stocks are traded under the ticker HJLI.
What is Hancock Jaffe Laboratories market cap?
Today Hancock Jaffe Laboratories has the market capitalization of 87.18M
What is Hancock Jaffe Laboratories revenue for the last year?
Hancock Jaffe Laboratories revenue for the last year amounts to 0 USD.
What is Hancock Jaffe Laboratories net income for the last year?
HJLI net income for the last year is -60.88M USD.
How many employees does Hancock Jaffe Laboratories have?
As of April 07, 2026, the company has 19 employees.
In which sector is Hancock Jaffe Laboratories located?
Hancock Jaffe Laboratories operates in the Manufacturing sector.
When did Hancock Jaffe Laboratories complete a stock split?
The last stock split for Hancock Jaffe Laboratories was on November 30, 2020 with a ratio of 1:25.
Where is Hancock Jaffe Laboratories headquartered?
Hancock Jaffe Laboratories is headquartered in Irvine, US.